TScan Therapeutics, Inc. earnings per share and revenue

TCRX earnings per share for the last quarter are -0.21 USD whereas the estimation was -0.29 USD which accounts for 27.38% surprise. Företagets omsättning för samma period uppgår till 7.21 M USD trots den uppskattade siffran 3.45 M USD. Estimated earnings per share for the next quarter are -0.26 USD, and revenue is expected to reach 4.30 M USD. Also watch annual changes over time to get a bigger picture of TCRX earnings per share and revenue dynamics.